Načítá se...
Vaccination produces CD4 T cells with a novel CD154-CD40 dependent cytolytic mechanism ()
The discovery of new vaccines against infectious diseases and cancer requires the development of novel adjuvants with well-defined activities. The TLR4 agonist adjuvant GLA-SE elicits robust TH1 responses to a variety of vaccine antigens and is in clinical development for both infectious diseases an...
Uloženo v:
| Vydáno v: | J Immunol |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4575887/ https://ncbi.nlm.nih.gov/pubmed/26297758 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4049/jimmunol.1501118 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|